Oxford Asset Management’s Q32 Bio QTTB Stock Holding History

Oxford Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,371	Closed	-$552K	–	2037
2018 Q4	$552K	Buy	+1,371	New	+$518K	0.01%	1155
2018 Q3	–	Sell	-1,396	Closed	-$507K	–	1967
2018 Q2	$507K	Sell	1,396 -4,051	-74%	-$1.45M	0.01%	1338
2018 Q1	$1.83M	Buy	+5,447	New	+$1.83M	0.04%	623

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Oxford Asset Management's QTTB Position: Q1 2019 in Review

Oxford Asset Management sold out of Q32 Bio (QTTB) in Q1 2019, closing a stake of 1,371 shares — an estimated $552K sold.

Oxford Asset Management first reported a position in QTTB in Q1 2018 and held it in 3 quarters. The position peaked at $1.83M in Q1 2018. 66 funds tracked by Wall St. Rank hold QTTB as of Q1 2019.

Oxford Asset Management reported no remaining Q32 Bio position as of Q1 2019 after selling out during the quarter.
Oxford Asset Management sold 1,371 Q32 Bio shares in Q1 2019, an estimated $552K.
Oxford Asset Management first reported a position in Q32 Bio in Q1 2018 and held it in 3 quarters.
Oxford Asset Management's Q32 Bio position peaked at $1.83M in Q1 2018.
66 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.